title: Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects.
abstract: Several studies have shown that hyperglycaemia slows gastric emptying in normal subjects and patients with diabetes mellitus but whether hyperinsulinaemia per se has an effect remains debatable. In the present study we have assessed the effect of hyperinsulinaemia on gastric emptying of a solid and liquid meal in normal subjects. Ten men were studied three times in random order. After an overnight fast, subjects were infused with 0.9% NaCl on two occasions and on the third with insulin, at 40 mU x m(-2) x min(-1) with 20% glucose simultaneously to maintain euglycaemia. Steady-state glucose infusion rate was ensured before the subjects ate a standard meal of a pancake labelled with 99mTc and milkshake labelled with (111)In-DTPA. Gamma-scintigraphic images were then obtained every 20 min for the next 3 h. There were no significant differences between the mean half-emptying times (T50) of the solid and liquid during the two saline infusions (129.6 +/- 28.5 vs 128.4 +/- 23.8 min for the solid and 25.4 +/- 7.0 vs 34.7 +/- 18.0 min for the liquid, mean +/- SD). Hyperinsulinaemia delayed both solid (mean T50 149.6 +/- 30.7, p = 0.031) and liquid emptying (mean T50 39.8 +/- 13.9, p = 0.042). There were no significant differences in the cholecystokinin and glucagon-like peptide 1 responses to the meal during either saline or insulin infusions. There was a tendency towards a greater insulin response to the meal during the hyperinsulinaemic study. Thus, hyperinsulinaemia delayed emptying of both the solid and liquid components of the meal.
authors.affiliation: Diabetes Unit, University Hospital, Queen's Medical Centre, Nottingham, UK.
authors.forename: M F
authors.initials: MF
authors.lastname: Kong
authors.forename: P
authors.initials: P
authors.lastname: King
authors.forename: I A
authors.initials: IA
authors.lastname: Macdonald
authors.forename: P E
authors.initials: PE
authors.lastname: Blackshaw
authors.forename: A C
authors.initials: AC
authors.lastname: Perkins
authors.forename: E
authors.initials: E
authors.lastname: Armstrong
authors.forename: K D
authors.initials: KD
authors.lastname: Buchanan
authors.forename: R B
authors.initials: RB
authors.lastname: Tattersall
mesh_terms: D000328:Adult; D000682:Amyloid / Q000097:blood / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood / Q000378:metabolism; D005746:Gastric Emptying / Q000187:drug effects / Q000502:physiology*; D005768:Gastrointestinal Hormones / Q000097:blood / Q000378:metabolism*; D005934:Glucagon / Q000097:blood / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D015309:Glucose Clamp Technique; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D058228:Islet Amyloid Polypeptide; D008297:Male; D004369:Pentetic Acid; D010446:Peptide Fragments / Q000097:blood / Q000378:metabolism; D011498:Protein Precursors / Q000097:blood / Q000378:metabolism; D019275:Radiopharmaceuticals; D012016:Reference Values; D013667:Technetium; D013997:Time Factors
chemical_list: D000682:Amyloid; D001786:Blood Glucose; D002096:C-Peptide; D005768:Gastrointestinal Hormones; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D010446:Peptide Fragments; D011498:Protein Precursors; D019275:Radiopharmaceuticals; D013667:Technetium; D004369:Pentetic Acid; D052216:Glucagon-Like Peptide 1; D005934:Glucagon